Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Baldacci, S. Maio, A. Angino, G. Sarno, S. Cerrai, M. Simoni, P. Silvi, F. Di Pede, A. P. Pala, M. Bresciani, G. Viegi (Pisa, Palermo, Italy). Determinants of non-adherence to pharmacologic allergic rhinitis treatment. Eur Respir J 2013; 42: Suppl. 57, 3839

Member's Comments

No comment yet.

Related content which might interest you: Allergic rhinitis does it have an impact on controller asthma therapy choice Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014 Risk factors of incomplete asthma control in asthmatic patients with allergic rhinitis Source: Annual Congress 2013 –Asthma Year: 2013 Predictors factors for asthma in patients with rhinitis Source: International Congress 2014 – Clinical allergy Year: 2014 Patients with allergic and eosinophilic asthma in the German severe asthma registry Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Relationship between specific rhinitis symptom and control status of asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Asthma control with omalizumab treatment in severe allergic asthma and severe non-allergic asthma patients Source: International Congress 2015 – Asthma and lung immunology Year: 2015 Efficacy of omalizumab in allergic asthma by asthma severity and eosinophilic status Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Combined therapy of asthma and allergic rhinitis Source: Annual Congress 2013 –Treatment of asthma Year: 2013 A phenotype of onset of adult asthma with co-morbid rhinitis Source: Annual Congress 2013 –Asthma Year: 2013 The ’real-life’ long-term efficacy of omalizumab in severe persistent IgE-mediated allergic asthma in Malta Source: International Congress 2016 – Asthma management Year: 2016 Finding asthmatics suitable for omalizumab therapy in a district hospital Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 25(OH) vitamin D levels in pediatric asthma and allergic rhinitis Source: International Congress 2014 – More paediatric asthma Year: 2014 Effect of vitamin d therapy on the pulmonary functions in pediatric asthma and allergic rhinitis Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 A new chemical causing IgE-mediated sensitization and asthma Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Ultra-rush sublingual immunotherapy: Safety of use for patients with various allergic manifestations Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Prevalence of refractory asthma in population with severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Barriers to adherence to asthma medication Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Clinical effectiveness of anti-IgE therapy in allergic severe asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Allergic versus non allergic asthma: What makes the difference? Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Adherence to the treatment of patients with bronchial asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015